Ardent Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $727K | Hold |
15,700
| – | – | 0.35% | 25 |
|
|
2025
Q1 | $958K | Hold |
15,700
| – | – | 0.41% | 21 |
|
|
2024
Q4 | $888K | Sell |
15,700
-10,283
| -40% | -$582K | 0.4% | 23 |
|
|
2024
Q3 | $1.34M | Hold |
25,983
| – | – | 0.61% | 15 |
|
|
2024
Q2 | $1.08M | Hold |
25,983
| – | – | 0.53% | 20 |
|
|
2024
Q1 | $1.41M | Hold |
25,983
| – | – | 0.71% | 16 |
|
|
2023
Q4 | $1.33M | Sell |
25,983
-2,000
| -7% | -$103K | 0.7% | 16 |
|
|
2023
Q3 | $1.62M | Buy |
+27,983
| New | +$1.62M | 0.92% | 14 |
|
|
2023
Q1 | – | Sell |
-7,358
| Closed | -$529K | – | 30 |
|
|
2022
Q4 | $529K | Buy |
+7,358
| New | +$529K | 0.41% | 16 |
|
|
2022
Q3 | – | Sell |
-5,108
| Closed | -$393K | – | 17 |
|
|
2022
Q2 | $393K | Buy |
5,108
+1,500
| +42% | +$115K | 0.48% | 15 |
|
|
2022
Q1 | $263K | Sell |
3,608
-1,500
| -29% | -$109K | 0.18% | 24 |
|
|
2021
Q4 | $318K | Buy |
+5,108
| New | +$318K | 0.21% | 26 |
|